{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:08:35Z","timestamp":1793642915311,"version":"4.5.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270168"],"award-info":[{"award-number":["82270168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58966-1","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:11:35Z","timestamp":1746547895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["m6A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability"],"prefix":"10.1038","volume":"16","author":[{"given":"Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-0235","authenticated-orcid":false,"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-0525","authenticated-orcid":false,"given":"Yueh-Chiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-3918","authenticated-orcid":false,"given":"Chengwu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-0399","authenticated-orcid":false,"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8737-6830","authenticated-orcid":false,"given":"Chun-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-2902","authenticated-orcid":false,"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2608-572X","authenticated-orcid":false,"given":"Huilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6474-2861","authenticated-orcid":false,"given":"Hengyou","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"58966_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015)","journal-title":"N. Engl. J. Med"},{"key":"58966_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).","journal-title":"Blood Cancer J."},{"key":"58966_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc2765","volume":"10","author":"J Chen","year":"2010","unstructured":"Chen, J., Odenike, O. & Rowley, J. D. Leukaemogenesis: more than mutant genes. Nat. Rev. Cancer 10, 23\u201336 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"58966_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104\u2013108 (2017).","journal-title":"Nature"},{"key":"58966_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnves.2025.100007","volume":"1","author":"S Hou","year":"2025","unstructured":"Hou, S., Liu, J. & Zhu, Y. Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig. 1, 100007 (2025).","journal-title":"Cell Investig."},{"key":"58966_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnves.2024.100001","volume":"1","author":"C Zeng","year":"2025","unstructured":"Zeng, C. Advances in cancer treatment: the role of new technologies and research. Cell Investig. 1, 100001 (2025).","journal-title":"Cell Investig."},{"key":"58966_CR7","doi-asserted-by":"publisher","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, https:\/\/doi.org\/10.1126\/science.aaw5473 (2020).","DOI":"10.1126\/science.aaw5473"},{"key":"58966_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J. & Thompson, C. B. The hallmarks of cancer metabolism: still emerging. Cell Metab. 34, 355\u2013377 (2022).","journal-title":"Cell Metab."},{"key":"58966_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740.e724 (2018).","journal-title":"Cancer Cell"},{"key":"58966_CR10","doi-asserted-by":"publisher","unstructured":"He, X. et al. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models. J. Clin. Invest. 131, https:\/\/doi.org\/10.1172\/JCI140242 (2021).","DOI":"10.1172\/JCI140242"},{"key":"58966_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1083\/jcb.201604085","volume":"214","author":"KR Mattaini","year":"2016","unstructured":"Mattaini, K. R., Sullivan, M. R. & Vander Heiden, M. G. The importance of serine metabolism in cancer. J. Cell Biol. 214, 249\u2013257 (2016).","journal-title":"J. Cell Biol."},{"key":"58966_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","volume":"3","author":"SL Geeraerts","year":"2021","unstructured":"Geeraerts, S. L., Heylen, E., De Keersmaecker, K. & Kampen, K. R. The ins and outs of serine and glycine metabolism in cancer. Nat. Metab. 3, 131\u2013141 (2021).","journal-title":"Nat. Metab."},{"key":"58966_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tcb.2017.05.001","volume":"27","author":"AC Newman","year":"2017","unstructured":"Newman, A. C. & Maddocks, O. D. K. Serine and functional metabolites in cancer. Trends Cell Biol. 27, 645\u2013657 (2017).","journal-title":"Trends Cell Biol."},{"key":"58966_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cmet.2020.12.005","volume":"33","author":"S Jeong","year":"2021","unstructured":"Jeong, S. et al. High fructose drives the serine synthesis pathway in acute myeloid leukemic cells. Cell Metab. 33, 145\u2013159.e146 (2021).","journal-title":"Cell Metab."},{"key":"58966_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372\u2013376 (2017).","journal-title":"Nature"},{"key":"58966_CR16","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1158\/2159-8290.CD-20-0738","volume":"11","author":"S Bjelosevic","year":"2021","unstructured":"Bjelosevic, S. et al. Serine biosynthesis is a metabolic vulnerability in FLT3-ITD\u2013driven acute myeloid leukemia. Cancer Discov. 11, 1582\u20131599 (2021).","journal-title":"Cancer Discov."},{"key":"58966_CR17","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.molcel.2021.05.008","volume":"81","author":"D Di Marcantonio","year":"2021","unstructured":"Di Marcantonio, D. et al. ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia. Mol. Cell 81, 2752\u20132764.e2756 (2021).","journal-title":"Mol. Cell"},{"key":"58966_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell 31, 127\u2013141 (2017).","journal-title":"Cancer Cell"},{"key":"58966_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen, C. et al. RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia. Cell Stem Cell 27, 64\u201380.e69 (2020).","journal-title":"Cell Stem Cell"},{"key":"58966_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","volume":"25","author":"J Paris","year":"2019","unstructured":"Paris, J. et al. Targeting the RNA m(6)A Reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell 25, 137\u2013148.e136 (2019).","journal-title":"Cell Stem Cell"},{"key":"58966_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201\u2013206 (2012).","journal-title":"Nature"},{"key":"58966_CR22","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell 149, 1635\u20131646 (2012).","journal-title":"Cell"},{"key":"58966_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi, H., Wei, J. & He, C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol. Cell 74, 640\u2013650 (2019).","journal-title":"Mol. Cell"},{"key":"58966_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang, Y., Hsu, P. J., Chen, Y. S. & Yang, Y. G. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 28, 616\u2013624 (2018).","journal-title":"Cell Res."},{"key":"58966_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu, L. P. et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat. Med. 23, 1369\u20131376 (2017).","journal-title":"Nat. Med."},{"key":"58966_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93\u201395 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"58966_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping, X. L. et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177\u2013189 (2014).","journal-title":"Cell Res."},{"key":"58966_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz, S. et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites. Cell Rep. 8, 284\u2013296 (2014).","journal-title":"Cell Rep."},{"key":"58966_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","volume":"567","author":"H Huang","year":"2019","unstructured":"Huang, H. et al. Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-transcriptionally. Nature 567, 414\u2013419 (2019).","journal-title":"Nature"},{"key":"58966_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885\u2013887 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"58966_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18\u201329 (2013).","journal-title":"Mol. Cell"},{"key":"58966_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng, Y. et al. N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell 39, 958\u2013972.e958 (2021).","journal-title":"Cancer Cell"},{"key":"58966_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu, P. J. et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 27, 1115\u20131127 (2017).","journal-title":"Cell Res."},{"key":"58966_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tig.2016.03.006","volume":"32","author":"IA Roundtree","year":"2016","unstructured":"Roundtree, I. A. & He, C. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Trends Genet. 32, 320\u2013321 (2016).","journal-title":"Trends Genet."},{"key":"58966_CR35","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","volume":"138","author":"Y Sheng","year":"2021","unstructured":"Sheng, Y. et al. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. Blood 138, 2838\u20132852 (2021).","journal-title":"Blood"},{"key":"58966_CR36","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara, S. & Jaffrey, S. R. A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA. Cell 181, 1582\u20131595.e1518 (2020).","journal-title":"Cell"},{"key":"58966_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285\u2013295 (2018).","journal-title":"Nat. Cell Biol."},{"key":"58966_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang, H., Weng, H. & Chen, J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell 37, 270\u2013288 (2020).","journal-title":"Cancer Cell"},{"key":"58966_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng, X., Qing, Y., Horne, D., Huang, H. & Chen, J. The roles and implications of RNA m(6)A modification in cancer. Nat. Rev. Clin. Oncol. 20, 507\u2013526 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"58966_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng, H. et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell 40, 1566\u20131582.e1510 (2022).","journal-title":"Cancer Cell"},{"key":"58966_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han, L. et al. METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell 30, 52\u201368.e13 (2023).","journal-title":"Cell Stem Cell"},{"key":"58966_CR42","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing, Y. et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis. Mol. Cell 81, 922\u2013939.e929 (2021).","journal-title":"Mol. Cell"},{"key":"58966_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.stem.2022.12.003","volume":"30","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y. et al. Decoding m(6)A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance. Cell Stem Cell 30, 69\u201385.e67 (2023).","journal-title":"Cell Stem Cell"},{"key":"58966_CR44","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy, T. et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature 586, 790\u2013795 (2020).","journal-title":"Nature"},{"key":"58966_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"OD Maddocks","year":"2013","unstructured":"Maddocks, O. D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542\u2013546 (2013).","journal-title":"Nature"},{"key":"58966_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20223-y","volume":"12","author":"M Tajan","year":"2021","unstructured":"Tajan, M. et al. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nat. Commun. 12, 366 (2021).","journal-title":"Nat. Commun."},{"key":"58966_CR47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi, M. et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature 605, 747\u2013753 (2022).","journal-title":"Nature"},{"key":"58966_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110278","volume":"38","author":"BH Choi","year":"2022","unstructured":"Choi, B. H. et al. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors. Cell Rep. 38, 110278 (2022).","journal-title":"Cell Rep."},{"key":"58966_CR49","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-21-4074","volume":"82","author":"MY Luo","year":"2022","unstructured":"Luo, M. Y. et al. Metabolic and nonmetabolic functions of PSAT1 coordinate signaling cascades to confer EGFR inhibitor resistance and drive progression in lung adenocarcinoma. Cancer Res. 82, 3516\u20133531 (2022).","journal-title":"Cancer Res."},{"key":"58966_CR50","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1073\/pnas.1521548113","volume":"113","author":"E Mullarky","year":"2016","unstructured":"Mullarky, E. et al. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc. Natl Acad. Sci. USA 113, 1778\u20131783 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58966_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19532-z","volume":"11","author":"A Yesbolatova","year":"2020","unstructured":"Yesbolatova, A. et al. The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. Nat. Commun. 11, 5701 (2020).","journal-title":"Nat. Commun."},{"key":"58966_CR52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang, M. & Vousden, K. H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16, 650\u2013662 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"58966_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng, H. et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell 22, 191\u2013205.e199 (2018).","journal-title":"Cell Stem Cell"},{"key":"58966_CR54","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola, G. M. et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat. Genet. 47, 1475\u20131481 (2015).","journal-title":"Nat. Genet."},{"key":"58966_CR55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.02.024","volume":"23","author":"SM Jeong","year":"2013","unstructured":"Jeong, S. M. et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450\u2013463 (2013).","journal-title":"Cancer Cell"},{"key":"58966_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng, M. et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood 138, 71\u201385 (2021).","journal-title":"Blood"},{"key":"58966_CR57","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41375-021-01393-0","volume":"36","author":"F Perner","year":"2022","unstructured":"Perner, F. et al. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia 36, 426\u2013437 (2022).","journal-title":"Leukemia"},{"key":"58966_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat. Commun. 14, 1011 (2023).","journal-title":"Nat. Commun."},{"key":"58966_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","volume":"29","author":"M Lederer","year":"2014","unstructured":"Lederer, M., Bley, N., Schleifer, C. & Huttelmaier, S. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin. Cancer Biol. 29, 3\u201312 (2014).","journal-title":"Semin. Cancer Biol."},{"key":"58966_CR60","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang, N. et al. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp. Mol. Med. 54, 194\u2013205 (2022).","journal-title":"Exp. Mol. Med"},{"key":"58966_CR61","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15706","volume":"11","author":"J Fan","year":"2023","unstructured":"Fan, J., Zhuang, M., Fan, W. & Hou, M. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA. PeerJ 11, e15706 (2023).","journal-title":"PeerJ"},{"key":"58966_CR62","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.celrep.2017.04.042","volume":"19","author":"Y Park","year":"2017","unstructured":"Park, Y., Reyna-Neyra, A., Philippe, L. & Thoreen, C. C. mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4. Cell Rep. 19, 1083\u20131090 (2017).","journal-title":"Cell Rep."},{"key":"58966_CR63","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nat. Cell Biol. 26, 2168\u20132182 (2024).","journal-title":"Nat. Cell Biol."},{"key":"58966_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"58966_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"58966_CR66","unstructured":"Andrews, S. FastQC: A Quality Control Tool for High Throughput Sequence Data. Available online: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"58966_CR67","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"58966_CR68","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","volume":"38","author":"GH Putri","year":"2022","unstructured":"Putri, G. H., Anders, S., Pyl, P. T., Pimanda, J. E. & Zanini, F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics 38, 2943\u20132945 (2022).","journal-title":"Bioinformatics"},{"key":"58966_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"58966_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"58966_CR71","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"58966_CR72","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58966-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58966-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58966-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T17:02:39Z","timestamp":1746550959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58966-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58966"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58966-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4214"}}